Immune-Checkpoint Inhibitors in the Era of Precision Medicine: What Radiologists Should Know

Over the past five years immune-checkpoint inhibitors have dramatically changed the therapeutic landscape of advanced solid and hematologic malignancies. The currently approved immune-checkpoint inhibitors include antibodies to cytotoxic T-lymphocyte antigen-4, programmed cell death (PD-1), and prog...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Korean J Radiol
Egile Nagusiak: Braschi-Amirfarzan, Marta, Tirumani, Sree Harsha, Hodi, Frank Stephen, Nishino, Mizuki
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: The Korean Society of Radiology 2017
Gaiak:
Cancer Imaging
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5240494/
https://ncbi.nlm.nih.gov/pubmed/28096717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3348/kjr.2017.18.1.42
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak